TBCE and steatosis: Depletion of phagocytic cells in the liver (including both KCs and RHMs) through the administration of either liposome-encapsulated clodronate or gadolinium chloride protects against high-fat- or high-sucrose-induced steatosis, inflammation, and IR, demonstrating critical role of hepatic macrophages in the development of metabolic dysfunction (65).